Your browser doesn't support javascript.
loading
Epilepsy in Christianson syndrome: Two cases of Lennox-Gastaut syndrome and a review of literature.
Ikeda, Azusa; Yamamoto, Ayako; Ichikawa, Kazushi; Tsuyusaki, Yu; Tsuji, Megumi; Iai, Mizue; Enomoto, Yumi; Murakami, Hiroaki; Kurosawa, Kenji; Miyatake, Satoko; Matsumoto, Naomichi; Goto, Tomohide.
Afiliação
  • Ikeda A; Department of Neurology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Yamamoto A; Department of Neurology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Ichikawa K; Department of Neurology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Tsuyusaki Y; Department of Neurology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Tsuji M; Department of Neurology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Iai M; Department of Neurology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Enomoto Y; Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Murakami H; Division of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Kurosawa K; Division of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Miyatake S; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Matsumoto N; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Goto T; Department of Neurology, Kanagawa Children's Medical Center, Yokohama, Japan.
Epilepsy Behav Rep ; 13: 100349, 2020.
Article em En | MEDLINE | ID: mdl-31879735
Christianson syndrome (CS) is an X-linked intellectual disorder caused by mutations in the SLC9A6 gene. Clinical features of CS include an inability to speak, truncal ataxia, postnatal microcephaly, hyperkinesis, and epilepsy. Almost all patients with CS develop drug-resistant epilepsy-its most serious complication. We report two cases of CS with drug-resistant epilpesy associated with the Lennox-Gastaut syndrome (LGS). One patient experienced generalized tonic seizures since 9 months of age with cognitive regression, which evolved to include atonic seizures at the age of 7 years. Electroencephalography (EEG) showed generalized slow spike-wave complexes and generalized paroxysmal fast activity. Seizures remained drug-resistant despite multiple anti-seizure drugs. The second patient experienced generalized tonic seizures since the age of 17 months and arrested development. EEG showed generalized slow spike-wave complexes, with frequent atonic seizures since the age of 6 years. Electrical status epilepticus during slow-wave sleep (ESES) developed at the age of 7 years. Our cases illustrate that CS may cause LGS in addition to other developmental and epileptic encephalopathies of the neonatal and infantile period. We suggest that generalized tonic or tonic-clonic seizures and generalized slow spike-wave complexes in interictal EEG be included as potential electroclinical features of epilepsy in CS.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Epilepsy Behav Rep Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Epilepsy Behav Rep Ano de publicação: 2020 Tipo de documento: Article